Similar Companies
+3 more
Sign in for full access
Short description
MgShell manufactures intraocular devices for treating exudative form of age-related macular degeneration.
Description
MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgical procedures.
Last funding
No Way
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Milan, Lombardia, Italy, Europe
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccessforu, Noway Youcantaccess, Absolutely Noaccess, Uh Ohhhh
Sign in for full access
Founders
Federica Boschetti, Francesco De Gaetano, Marco Ferroni, Matteo Giuseppe Cereda